KIT and freckles: AOPT‐LTL treatment significantly enhances the improvement of melasma by diminishing melanogenesis, inflammation, angiogenesis, mast cell infiltration, and collagen degeneration, potentially through the inhibition of the SCF/c‐KIT ligand/receptor pathway.